October 17, 2025 biotechnology / China News / clinical development / Hong Kong IPO / I-Mab / Industry / NovaBridge Biosciences I-Mab Unveils Strategic Changes, Hong Kong IPO Plans, and Rebrands to NovaBridge Biosciences Source: ChinaMoneyNetwork.com Continue